Clinical Trials
5
Active:0
Completed:0
Trial Phases
1 Phases
Early Phase 1:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Early Phase 1
5 (100.0%)Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT06541444
- Locations
- 🇨🇳
Shanghai Pudong Hospital, Shanghai, Shanghai, China
Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT06541405
- Locations
- 🇨🇳
Shanghai Children's Medical Center, Shanghai, Shanghai, China
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06117878
- Locations
- 🇨🇳
Shanghai General Hospital, Shanghai, China
Safety and Efficacy of NK510 to Treat Gastric Cancer
Early Phase 1
- Conditions
- Gastric Cancer
- Interventions
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT06098898
- Locations
- 🇨🇳
Shanghai Tenth People's Hospital, Shanghai, China
Safety and Efficacy of NK510 to Treat NSCLC
Early Phase 1
Recruiting
- Conditions
- NSCLC
- Interventions
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT06097962
- Locations
- 🇨🇳
General Hospital of Eastern Theater Command, Nanjing, Jiangsu, China
News
No news found